Company intelligence / Profile preview

Glastad Invest

Farsund, Norway

Ownership: Private
Development stage: Other

Overview

Glastad Invest is a Norwegian family-owned investment company based in Farsund, managed by Endre Glastad. The firm maintains a diversified portfolio across several industries, with a significant strategic focus on the life sciences and biotechnology sectors. Notably, Glastad Invest is a major shareholder in Arctic Bioscience, a company developing marine-derived treatments for inflammatory diseases like psoriasis. Beyond healthcare, the group has substantial interests in shipping, real estate, and seafood. The company operates as a long-term industrial owner, providing capital and strategic guidance to its portfolio companies. It is recognized for its commitment to sustainable development and regional economic growth in Norway.

Industry: Investors

Beyond the preview

Go deeper on Glastad Invest.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glastad Invest.

Explore the full profile